A detailed history of Merit Financial Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Merit Financial Group, LLC holds 9,781 shares of NVS stock, worth $956,288. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,781
Previous 10,608 7.8%
Holding current value
$956,288
Previous $1.13 Million 0.35%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$106.13 - $120.89 $87,769 - $99,976
-827 Reduced 7.8%
9,781 $1.13 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $8,609 - $9,985
93 Added 0.88%
10,608 $1.13 Million
Q1 2024

May 06, 2024

BUY
$95.27 - $108.47 $810,652 - $922,971
8,509 Added 424.18%
10,515 $1.02 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $185,093 - $203,689
2,006 New
2,006 $202,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $210B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.